To access this element change to forms mode OFF
Grant Award View - GA65850
Personalised medicine for inflammatory and thrombotic diseases:...
GA ID:
GA65850
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$745,955.29
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Personalised medicine for inflammatory and thrombotic diseases: Generating novel and transformative diagnostic, therapeutic and theranostic approaches
Purpose:
Three novel biotechnological concepts will be developed in this proposal. 1) A safe (no increased bleeding risk), targeted clot-busting drug used both for treatment and prophylaxis of thrombosis. 2) Molecular ultrasound imaging using microbubbles directed to markers of blood clots and early inflammatory reactions for rapid/definitive diagnosis of heart diseases. 3) Ultimately, using drug-loaded targeted microbubbles will allow concurrent ultrasound imaging/diagnosis and localised drug delivery.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1185314
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Baker Heart and Diabetes Institute
Recipient ABN:
98 131 762 948
Grant Recipient Location
Suburb:
Melbourne
Town/City:
Melbourne
Postcode:
3004
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA